Back to InsightsPolicy Brief

Strengthening Drug Monitoring Systems in Bangladesh

Policy recommendations for building a robust national drug surveillance system.

RMCL InsightResearch & Management Consultants Ltd

Overview

Bangladesh requires a stronger, integrated drug monitoring system to track emerging substances, geographic hotspots, treatment demand, relapse patterns, and policy impact. Current information sources are often fragmented across enforcement, treatment, health, and community-level systems, limiting the ability of decision-makers to respond quickly and allocate resources effectively. A national drug monitoring system should combine routine administrative data, periodic surveys, treatment center reporting, early warning indicators, and community intelligence into a unified evidence platform.

Key Findings

  • Existing drug-related data systems are fragmented across multiple agencies and reporting formats.
  • Emerging stimulant use, including yaba and other synthetic substances, requires faster early warning mechanisms.
  • Treatment and rehabilitation data are not consistently linked with prevention, enforcement, and public health systems.
  • Regional hotspot analysis remains limited due to inconsistent geographic reporting and weak data integration.
  • Relapse, recovery, and treatment outcome indicators are not routinely monitored at national scale.
  • Limited use of digital dashboards reduces the ability to translate data into timely policy and program decisions.

Implications for Policy & Practice

  1. 1

    Establish a national drug monitoring framework led by the Department of Narcotics Control with clear data governance protocols.

  2. 2

    Integrate data from enforcement, treatment, health, social services, and research systems into a unified reporting platform.

  3. 3

    Develop early warning indicators for emerging substances, regional hotspots, and changes in user profiles.

  4. 4

    Strengthen digital dashboards to support evidence-based planning, resource allocation, and program monitoring.

  5. 5

    Institutionalize periodic national surveys and rapid assessments to complement routine administrative data.

Methodological Note

Technical Note

This policy brief is informed by national drug research, administrative data review, stakeholder consultations, and analysis of prevention, treatment, and enforcement information systems. The proposed monitoring approach combines routine reporting, periodic survey evidence, hotspot mapping, and early warning indicators to support a more coordinated national response.